http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012128501-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86371a1ff6fcd18e1c6eb0a7fd37c31e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44cb55a8b7edb77b5891f7236753a1dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ede47b877b6df9c8d0c494cd66f45ae8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2012-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1e3a323b17bc8e99d10214930f34ebf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d2aaf47d36493bac698c3ac49a29ca
publicationDate 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012128501-A2
titleOfInvention Pharmaceutical composition containing, as an active ingredient, m-3m3fbs, which is an activator of phospholipase c, for preventing or treating inflammatory diseases or infectious diseases
abstract The objective of the present invention is to provide a pharmaceutical composition containing, as an active ingredient, m -3M3FBS or a pharmaceutically acceptable salt thereof for preventing or treating inflammatory diseases or infectious diseases. Further, another objective of the present invention is to provide a functional health food containing m -3M3FBS for preventing or treating inflammatory diseases or infectious diseases. The m -3M3FBS of the present invention exhibits germicidal effects, apoptosis-inhibiting effects, and effects of inhibiting LPS-related signaling, and thus enables the effective treatment or prevention of inflammatory diseases or infectious diseases. Therefore, the m -3M3FBS of the present invention can be effectively used in a pharmaceutical product or functional health food for treating or preventing inflammatory diseases or infectious diseases.
priorityDate 2011-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004220268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004038976-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44634701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6364615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421056

Total number of triples: 36.